Acrivon Therapeutics Announces $130 Million Private Placement Financing

WATERTOWN, Mass, April 09, 2024 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...

Related Keywords

United States ,Peter Blume Jensen ,Alexandra Santos ,Drug Administration ,Exchange Commission ,Acrivon Therapeutics Inc ,Acrivon Predictive Precision Proteomics ,Perceptive Advisors ,Paradigm Biocapital ,Surveyor Capital ,Sands Capital ,Securities Act ,Fast Track ,Breakthrough Device ,Private Securities Litigation Reform Act ,Media Contacts ,Markets ,